LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma.
about
Macrophage-mediated cholesterol handling in atherosclerosisHypertension with elevated levels of oxidized low-density lipoprotein and anticardiolipin antibody in the circulation of premenopausal Indian women chronically exposed to biomass smoke during cooking.LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.The discovery of LOX-1, its ligands and clinical significance.Formulation and Characterization of Pyrazinamide Polymeric Nanoparticles for Pulmonary Tuberculosis: Efficiency for Alveolar Macrophage Targeting.Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes.Protein Inhibitor of Activated STAT3 Suppresses Oxidized LDL-induced Cell Responses during Atherosclerosis in Apolipoprotein E-deficient Mice.The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.LOX-1, OxLDL, and atherosclerosisLipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages.Oxidative Stress in Cardiovascular Diseases: Involvement of Nrf2 Antioxidant Redox Signaling in Macrophage Foam Cells Formation.Oxidative Stress in Atherosclerosis.Recombinant Human Thioredoxin-1 Protects Macrophages from Oxidized Low-Density Lipoprotein-Induced Foam Cell Formation and Cell Apoptosis.Mechanisms of foam cell formation in atherosclerosis.
P2860
Q26780405-2823DD15-FE3D-4499-A733-8F8BEADF64B3Q33758925-3E9B30B0-7073-4460-8A9B-325A922B473CQ34079451-991E921E-CCB8-4B55-A84F-78090E15395AQ35475499-7D9EC79C-A060-446E-800F-1AC12175D28EQ35693217-DF259DB2-F416-4902-89EE-C5A69A44B4B8Q37065040-ADC9043C-544B-4909-8A3B-31739AA1DA6EQ37414017-8FD6C39C-EB97-490A-9D15-49B252A203ABQ38025997-2E97CCD6-90C6-475D-A4FF-A4BFE7B9C401Q38128283-AD72FAF2-FD93-4F47-B1EE-74D360B5798CQ38944787-0B5AADAD-6783-4BC1-8E6D-24DB289BF765Q46266568-F21593A2-08D4-4A9D-B9C5-D608413DAAB7Q46305239-E466E49B-A32D-4DAA-8FC7-32AF28041FA2Q46359476-DFD72196-BD72-4D13-AC03-73578A848E96Q52759762-488E4AD3-3932-4471-9EFC-80C74987CEAE
P2860
LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
LOX-1 augments oxLDL uptake by ...... r oxLDL clearance from plasma.
@en
LOX-1 augments oxLDL uptake by ...... r oxLDL clearance from plasma.
@nl
type
label
LOX-1 augments oxLDL uptake by ...... r oxLDL clearance from plasma.
@en
LOX-1 augments oxLDL uptake by ...... r oxLDL clearance from plasma.
@nl
prefLabel
LOX-1 augments oxLDL uptake by ...... r oxLDL clearance from plasma.
@en
LOX-1 augments oxLDL uptake by ...... r oxLDL clearance from plasma.
@nl
P2093
P2860
P1476
LOX-1 augments oxLDL uptake by ...... r oxLDL clearance from plasma.
@en
P2093
David F Schaeffer
Johnny H Chen
Kuljit S Parhar
Maziar Riazy
Tatsuya Sawamura
Urs P Steinbrecher
Vincent Duronio
P2860
P304
P356
10.1194/JLR.M900167-JLR200
P577
2009-04-09T00:00:00Z